Synthesize Bio uses AI to reduce data collection and analysis for a fraction of the cost in time, personnel, and materials.
Synthesize Bio has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in September 2025.
Synthesize Bio's investors include Madrona, Inner Loop Capital, AI2 Incubator, Sahsen Ventures, Point Field Partners.
Synthesize Bio is headquartered in Seattle, United States.
Synthesize Bio uses AI to reduce data collection and analysis for a fraction of the cost in time, personnel, and materials.
Synthesize Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synthesize Bio — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/synthesize-bio. Accessed October 1, 2026.
VCBacked. (2025). Synthesize Bio — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/synthesize-bio
{{cite web |title=Synthesize Bio — Funding & Investors |url=https://www.vcbacked.co/company/synthesize-bio |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated